Menu
GWAS Study

Common-variant and rare-variant genetic architecture of heart failure across the allele-frequency spectrum.

Lee DSM, Cardone KM, Zhang DY et al.

40195560 PubMed ID
GWAS Study Type
2358556 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

LD
Lee DSM
CK
Cardone KM
ZD
Zhang DY
TN
Tsao NL
AS
Abramowitz S
SP
Sharma P
DJ
DePaolo JS
CM
Conery M
AK
Aragam KG
BK
Biddinger K
DO
Dikilitas O
HL
Hoffman-Andrews L
JR
Judy RL
KA
Khan A
KI
Kullo IJ
PM
Puckelwartz MJ
RN
Reza N
SB
Satterfield BA
SP
Singhal P
AZ
Arany Z
CT
Cappola TP
CE
Carruth ED
DS
Day SM
DR
Do R
HC
Haggerty CM
JJ
Joseph J
ME
McNally EM
NG
Nadkarni G
OA
Owens AT
RD
Rader DJ
RM
Ritchie MD
SY
Sun YV
VB
Voight BF
LM
Levin MG
DS
Damrauer SM
Chapter II

Abstract

Summary of the research findings

Heart failure is a complex trait, influenced by environmental and genetic factors, affecting over 30 million individuals worldwide. Here we report common-variant and rare-variant association studies of all-cause heart failure and examine how different classes of genetic variation impact its heritability. We identify 176 common-variant risk loci at genome-wide significance in 2,358,556 individuals and cluster these signals into five broad modules based on pleiotropic associations with anthropomorphic traits/obesity, blood pressure/renal function, atherosclerosis/lipids, immune activity and arrhythmias. In parallel, we uncover exome-wide significant associations for heart failure and rare predicted loss-of-function variants in TTN, MYBPC3, FLNC and BAG3 using exome sequencing of 376,334 individuals. We find that total burden heritability of rare coding variants is highly concentrated in a small set of Mendelian cardiomyopathy genes, while common-variant heritability is diffusely spread throughout the genome. Finally, we show that common-variant background modifies heart failure risk among carriers of rare pathogenic truncating variants in TTN. Together, these findings discern genetic links between dysregulated metabolism and heart failure and highlight a polygenic component to heart failure not captured by current clinical genetic testing.

168,363 European ancestry cases, 1,725,558 European ancestry controls, 21,202 African ancestry cases, 121,670 African ancestry controls, 12,665 East Asian ancestry cases, 245,263 East Asian ancestry controls, 5,116 Hispanic or Latin American cases, 58,719 Hispanic or Latin American controls

Chapter III

Study Statistics

Key metrics and study information

2358556
Total Participants
GWAS
Study Type
No
Replicated
European, African unspecified, East Asian, Hispanic or Latin American
Ancestry
Canada, Netherlands, Sweden, U.S., Japan, Denmark, U.K., Iceland, Germany, Estonia
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.